FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

734570008: Sodium glucose cotransporter subtype 2 inhibitor (disposition)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3509180010 Sodium glucose cotransporter subtype 2 inhibitor (disposition) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3509181014 Sodium glucose cotransporter subtype 2 inhibitor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium glucose cotransporter subtype 2 inhibitor (disposition) Is a Cellular transport inhibitor (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Sodium glucose cotransporter subtype 2 inhibitor This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. True Sodium glucose cotransporter subtype 2 inhibitor (disposition) Inferred relationship Some
Dapagliflozin (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. True Sodium glucose cotransporter subtype 2 inhibitor (disposition) Inferred relationship Some
Dapagliflozin propanediol This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. True Sodium glucose cotransporter subtype 2 inhibitor (disposition) Inferred relationship Some
Canagliflozin This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. True Sodium glucose cotransporter subtype 2 inhibitor (disposition) Inferred relationship Some
Empagliflozin This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. True Sodium glucose cotransporter subtype 2 inhibitor (disposition) Inferred relationship Some
Canagliflozin hemihydrate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. True Sodium glucose cotransporter subtype 2 inhibitor (disposition) Inferred relationship Some
Ertugliflozin This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. True Sodium glucose cotransporter subtype 2 inhibitor (disposition) Inferred relationship Some
Dapagliflozin propanediol monohydrate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. True Sodium glucose cotransporter subtype 2 inhibitor (disposition) Inferred relationship Some
Ertugliflozin pidolate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. True Sodium glucose cotransporter subtype 2 inhibitor (disposition) Inferred relationship Some
Remogliflozin etabonate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. True Sodium glucose cotransporter subtype 2 inhibitor (disposition) Inferred relationship Some
Canagliflozin anhydrous This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. True Sodium glucose cotransporter subtype 2 inhibitor (disposition) Inferred relationship Some
Dapagliflozin propanediol anhydrous This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. True Sodium glucose cotransporter subtype 2 inhibitor (disposition) Inferred relationship Some

This concept is not in any reference sets

Back to Start